3M to make $146M in­vest­ment in­to pro­duc­ing bio­phar­ma tech­nol­o­gy

3M, the man­u­fac­tur­er known for mak­ing of­fice sup­plies and tape, is adding to its biotech man­u­fac­tur­ing ca­pa­bil­i­ties with a $146 mil­lion in­vest­ment.

The Min­neso­ta-based man­u­fac­tur­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.